SureTrader
Home > Boards > US Listed > Biotechs >

Bioverativ Inc. (BIVV)

BIVV RSS Feed
Add BIVV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/21/2018 9:01:35 PM - Followers: 2 - Board type: Free - Posts Today: 0

About Bioverativ Bioverativ is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific innovation and is committed to actively working with the blood disorders community. The company’s mission is to create progress for patients where they need it most and its hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.com or follow @bioverativ on Twitter. Bioverativ Inc. MEDIA CONTACT: Tracy Vineis, +1 781-663-4350 media@bioverativ.com or INVESTOR CONTACT: Susan Altschuller, +1 781-663-4360 IR@bioverativ.com
SureTrader
BIVV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
BIVV News: Amended Statement of Ownership (sc 13g/a) 04/10/2018 11:16:10 AM
BIVV News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 03/19/2018 04:37:18 PM
BIVV News: Statement of Changes in Beneficial Ownership (4) 03/08/2018 12:54:41 PM
BIVV News: Statement of Changes in Beneficial Ownership (4) 03/08/2018 12:50:35 PM
BIVV News: Statement of Changes in Beneficial Ownership (4) 03/08/2018 12:45:49 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!